TrialPituitary2010

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension.

Shlomo Melmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.